FDA Inspection 1069102 — Penn Medicine Lancaster General Hospital
The FDA completed an inspection of Penn Medicine Lancaster General Hospital on Aug 30, 2018 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)